However, the use of CBZ is limited due to the effects of drug–drug interaction involving the cytochrome p450; hence, the use of CBZ decreases the PRL level, in turn decreasing the prevalence of depression, while the use of LEV increases the PRL level. This evidence concerns the gene PRL and major depressive disorder.